Used in research to inhibit the B-Raf kinase enzyme, particularly in studies involving the MAPK/ERK signaling pathway. It helps investigate cancer cell proliferation, especially in melanoma and other tumors with B-Raf mutations. Often applied in vitro to assess pathway inhibition and evaluate potential therapeutic strategies. Supports development of targeted cancer therapies and is utilized in combination studies with other inhibitors to overcome drug resistance.